Beam Therapeutics Inc. (BMV:BEAM)
Mexico · Delayed Price · Currency is MXN 461.00
0.00 (0.00%)
At close: Dec 3, 2025
Beam Therapeutics Revenue
Beam Therapeutics had revenue of $9.70M USD in the quarter ending September 30, 2025, a decrease of -32.03%. This brings the company's revenue in the last twelve months to $55.70M, down -84.07% year-over-year. In the year 2024, Beam Therapeutics had annual revenue of $63.52M, down -83.18%.
Revenue (ttm)
$55.70M
Revenue Growth
-84.07%
P/S Ratio
47.61
Revenue / Employee
$115.32K
Employees
483
Market Cap
48.64B MXN
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 63.52M | -314.19M | -83.18% |
| Dec 31, 2023 | 377.71M | 316.79M | 520.01% |
| Dec 31, 2022 | 60.92M | 9.08M | 17.51% |
| Dec 31, 2021 | 51.84M | 51.82M | 215,916.67% |
| Dec 31, 2020 | 24.00K | 6.00K | 33.33% |
| Dec 31, 2019 | 18.00K | - | - |
| Dec 31, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wal-Mart de México | 1.00T |
| Arca Continental | 250.90B |
| Industrias Peñoles | 142.01B |
| Grupo Financiero Banorte | 134.72B |
| Grupo Elektra | 114.48B |
| GMéxico Transportes | 64.06B |
| Becle | 44.91B |
| Gentera | 35.24B |